Accessibility Menu
 
Poniard Pharmaceuticals logo

Poniard Pharmaceuticals

(OTC) PARD

Current Price$0.00
Market Cap$100
Since IPO (1988)-100%
5 Year-100%
1 Year+9,900%
1 Month+0%

Poniard Pharmaceuticals Financials at a Glance

Market Cap

$100

Revenue (TTM)

$0.00

Net Income (TTM)

$16.04M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-409.80 (Low)

Price

$0.00

Volume

2

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

PARD News

PARD: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Poniard Pharmaceuticals

Industry

Biotechnology

Headquarters

Seattle, WA 98119, US

PARD Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-3%

Return on Assets

-3%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.00

Shares Outstanding

1.50M

Volume

2

Short Interest

0.00%

Avg. Volume

4.771

Financials (TTM)

Gross Profit

$0.00

Operating Income

$27.96M

EBITDA

$25.02M

Operating Cash Flow

$24.28M

Capital Expenditure

$7.00K

Free Cash Flow

$24.28M

Cash & ST Invst.

$4.33M

Total Debt

$1.57M

Poniard Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2011YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$100.00

N/A

Market Cap/Employee

$14.29

N/A

Employees

7

N/A

Net Income

$3.77M

+41.5%

EBITDA

$3.44M

+38.9%

Quarterly Fundamentals

Name
Q3 2011YOY CHG

Net Cash

$344.00K

-96.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.64M

-75.1%

Short Term Debt

$0.00

-100.0%

Return on Assets

-2.58%

N/A

Return on Invested Capital

-2.79%

N/A

Free Cash Flow

$1.71M

+56.0%

Operating Cash Flow

$1.71M

+55.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
XSNXNovAccess Global Inc.
$0.00+0.00%
RCARRenovaCare, Inc.
$0.00+0.00%
VAXXVaxxinity, Inc.
$0.00+0.00%
QBIOQ BioMed Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
INFYInfosys
$13.12+0.01%

Questions About PARD

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.